Vimian Group AB VIMIAN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 35.95
- Day Range
- SEK 35.80–37.00
- 52-Week Range
- SEK 24.18–37.00
- Bid/Ask
- SEK 36.85 / SEK 37.00
- Shares Outstanding
- 528.08M
- Market Cap
- SEK 19.46B
- Volume/Avg
- 151,120 / 404,619
Key Statistics
- Price/Earnings (Normalized)
- 35.72
- Price/Sales
- 3.86
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,300
- Website
- https://www.vimian.com
Valuation
|
Metric
|
VIMIAN
|
|---|---|
Price/Earnings (Normalized) | 35.72 |
Price/Book Value | 2.33 |
Price/Sales | 3.86 |
Price/Cash Flow | 21.96 |
Price/Earnings
VIMIAN
Financial Strength
|
Metric
|
VIMIAN
|
|---|---|
Quick Ratio | 1.49 |
Current Ratio | 2.43 |
Interest Coverage | 3.39 |
Quick Ratio
VIMIAN
Profitability
|
Metric
|
VIMIAN
|
|---|---|
Return on Assets (Normalized) | 3.32% |
Return on Equity (Normalized) | 5.38% |
Return on Invested Capital (Normalized) | 5.52% |
Return on Assets
VIMIAN
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|YyNl^C&P | LOCK|<v | $245B | |||
| Danaher Corp
DHR
| LOCK|nY%d^$BG | LOCK|f? | $156B | |||
| Agilent Technologies Inc
A
| LOCK|!N?gSY> | LOCK|$&< | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|l#sHB<& | LOCK|Vx$n | $43B | |||
| Waters Corp
WAT
| LOCK|>wDg&LB | LOCK|^Ft | $42B | |||
| Illumina Inc
ILMN
| LOCK|G%bzzG> | LOCK|FC#N$ | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|^p$>h>J% | LOCK|N#s | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|qhsdlR< | LOCK|&!># | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|&JVCsX | LOCK|sh<K | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|fXnk<SmY | LOCK|fBS$& | $26B |
United States